77999-24-7

Basic information

• Product Name: 1,5-Imidazolidinedicarboxylic acid, 2-oxo-, 5-(1,1-dimethylethyl) 1-(phenylmethyl) ester, (S)-
• CAS NO: 77999-24-7
• Molecular Formula: C16H20N2O5
• Molecular Weight: 320.345
• Mol File: 77999-24-7.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: 1,5-Imidazolidinedicarboxylic acid, 2-oxo-, 5-(1,1-dimethylethyl) 1-(phenylmethyl) ester, (S)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1,5-Imidazolidinedicarboxylic acid, 2-oxo-, 5-(1,1-dimethylethyl) 1-(phenylmethyl) ester, (S)-(77999-24-7)
• EPA Substance Registry System: 1,5-Imidazolidinedicarboxylic acid, 2-oxo-, 5-(1,1-dimethylethyl) 1-(phenylmethyl) ester, (S)-(77999-24-7)

Safety Data

• Hazardous Substances Data: 77999-24-7(Hazardous Substances Data)

Usage

General Description

The chemical "1,5-Imidazolidinedicarboxylic acid, 2-oxo-, 5-(1,1-dimethylethyl) 1-(phenylmethyl) ester, (S)-" is a compound that belongs to the class of imidazolidines. It is an ester derivative of imidazolidinedicarboxylic acid and contains a 1-(phenylmethyl) group. The compound has a chiral center and exists as a single enantiomer, designated as the (S)-enantiomer. This chemical may have potential applications in pharmaceuticals, agrochemicals, or other industrial processes, depending on its specific properties and reactivity. Additionally, its chirality may make it useful in asymmetric synthesis and catalysis.

Upstream product

• 4474-86-6 (R)-4-amino-2-(((benzyloxy)carbonyl)amino)-4-oxobutanoic acid 
• 59760-01-9 (S)-2-oxo-imidazolidine-1,5-dicarboxylic acid 1-benzyl ester 
• 75-65-0 tert-butyl alcohol 

Downstream Products

• 83056-89-7 (S)-3-ethyl-2-oxoimidazolidine-1,5‐dicarboxylic acid 5‐tert‐butyl ester 1‐benzyl ester 
• 845543-46-6 (S)-1-benzyl 4-tert-butyl 3-methyl-2-oxoimidazolidine-1,4-dicarboxylate 
• 1134289-52-3 (S)-3-butyryl-2-oxo-imidazolidine-1,5-dicarboxylic acid 1-benzyl ester 5-t-butyl ester 
• 83057-00-5 (S)-3-benzyl-2-oxo-imidazolidine-1,5-dicarboxylic acid 1-benzyl ester 5-t-butyl ester 
• 83066-87-9 tert.-butyl (4S)-1-n-butyl-3-benzyloxycarbonyl-2-oxo-imidazolidine-4-carboxylate 
• 122505-99-1 C₂₄H₂₈N₂O₅ 
• 41371-53-3 (S)-2-oxoimidazolidine-4-carboxylic acid 
• 89396-95-2 tert-butyl (4S)-1-benzyl-3-<(2R)-2-amino>propionyl>-2-oxoimidazolidine-4-carboxylate 
• 89371-55-1 tert-butyl (4S)-1-benzyl-3-<(2S)-2-amino>propionyl>-2-oxoimidazolidine-4-carboxylate 

Relevant articles and documents

Organic impurities of imidapril hydrochloride and preparation method thereof

The invention discloses three brand-new organic impurities of imidapril hydrochloride and a preparation method thereof. The structural formula of the impurity is shown as a formula I or a formula II which is shown in the specification, wherein R in the fo

GRANZYME B INHIBITOR FORMULATIONS AND METHODS FOR THE TREATMENT OF BURNS

Formulations for treating burns and burn wound healing comprising a Granzyme B inhibitor and a pharmaceutically acceptable carrier, and methods for treating burns and for burn wound healing using the formulations.

Identification of 2-oxo-N-(phenylmethyl)-4-imidazolidinecarboxamide antagonists of the P2X7 receptor

A backup molecule to compound 2 was sought by targeting the most likely metabolically vulnerable site in this molecule. Compound 18 was subsequently identified as a potent P2X7 antagonist with very low in vivo clearance and high oral bioavailability in all species examined. Some evidence to support the role of P2X7 in the etiology of pain is also presented.